BackgroundCheck.run
Search For

Michael E Pride, 57Stroudsburg, PA

Known as:
Michael Edward Pride Mike Pride
Related to:
Pamela Lynn White 62

Michael Pride Phones & Addresses

Stroudsburg, PA   

17110 107Th St, Jamaica, NY 11433    718-2620825   

340 Bristol St, Brooklyn, NY 11212    718-5662210   

440 Watkins St APT 6H, Brooklyn, NY 11212   

Rocky Hill, CT   

Atlantic Hl, NJ   

Atlantic City, NJ   

Get Report
Control this profile

Mentions for Michael E Pride

Resumes & CV records

Resumes

Michael Pride Photo 28

Principal At Mkp Property Analysis

Position:
Principal at MKP Property Analysis
Location:
Greater New York City Area
Industry:
Real Estate
Work:
MKP Property Analysis since 2009
Principal Advent Development Partners 2006 - 2008
Principal Hines Interests 1997 - 2006
Sr, Manager - Acquisitions / Development
Education:
Indiana University - Kelley School of Business
Skills:
Licensed Broker - NY, Lease & Contract Negotiation, Investment Management, Development Projects, Real Estate Acquisitions, Asset Managment, Project Planning
Michael Pride Photo 29

Michael Pride

Location:
Greater New York City Area
Industry:
Pharmaceuticals
Michael Pride Photo 30

Veterinarian At Cedars Veterinary Hospital

Position:
Veterinarian at Cedars Veterinary Hospital
Location:
Greater New York City Area
Industry:
Medical Practice
Work:
Cedars Veterinary Hospital
Veterinarian
Education:
Rutgers, The State University of New Jersey-New Brunswick
Michael Pride Photo 31

Director At Pfizer

Position:
Associate Director at Wyeth Research, Director at Pfizer
Location:
Greater New York City Area
Industry:
Pharmaceuticals
Work:
Wyeth Research
Associate Director Pfizer since Mar 1997
Director
Michael Pride Photo 32

Michael Pride

Location:
Greater New York City Area
Industry:
Transportation/Trucking/Railroad

Publications & IP owners

Us Patents

Method Of Immunizing Against Hepatitis B Virus

US Patent:
6319501, Nov 20, 2001
Filed:
Nov 12, 1993
Appl. No.:
8/150776
Inventors:
Alexander Robert Neurath - New York NY
Nathan Strick - New York NY
Yasmin M. Thanavala - Buffalo NY
Michael W. Pride - Buffalo NY
Assignee:
Health Research, Inc. - Buffalo NY
International Classification:
A61K 3929
C07K 1402
US Classification:
4241891
Abstract:
A method for immunizing a human against hepatitis B virus comprising administering to the human a vaccine comprising a hepatitis B virus surface antigen, wherein included in the vaccine is one or more antigens of non-permitted variant sequences within residues S(139-147) of the hepatitis B virus surface antigen.

Immunogenic Compositions For Use In Pneumococcal Vaccines

US Patent:
2021039, Dec 23, 2021
Filed:
Sep 1, 2021
Appl. No.:
17/463691
Inventors:
- New York NY, US
Kathrin Ute Jansen - New York NY, US
Michael William Pride - Staten Island NY, US
International Classification:
A61K 39/09
A61K 39/385
Abstract:
An object of the present invention is to provide immunogenic compositions for protection against , in particular against serogroup 9, while limiting the number of conjugates. The present invention therefore relates to new immunogenic compositions for use in pneumococcal vaccines and to vaccination of human subjects, in particular infants and elderly, against pneumoccocal infections using said immunogenic compositions.

Compositions And Methods For Eliciting An Immune Response Against Clostridium Difficile

US Patent:
2020025, Aug 13, 2020
Filed:
Sep 14, 2018
Appl. No.:
16/647124
Inventors:
- New York NY, US
Annaliesa Sybil Anderson - Upper Saddle River NJ, US
Robert G.K. Donald - South Orange NJ, US
Michael James Flint - Decatur GA, US
Nicholas Randolph Everard Kitchin - Sandwich, GB
Justin Keith Moran - West Nyack NY, US
Louise Pedneault - New York NY, US
Michael W. Pride - Staten Island NY, US
Mark Edward Ruppen - Cresco PA, US
Christopher Frederick Webber - Sandwich, GB
International Classification:
A61K 39/08
A61K 9/19
Abstract:
In one aspect, the invention relates to an immunogenic composition that includes a toxoid A and/or a toxoid B, and methods of use thereof. In another aspect, the invention relates to a method for eliciting an immune response in a human against a infection. The method includes administering to the human an effective dose of a composition, which includes a toxoid, wherein the composition is administered at least two times, wherein the second administration is about 30 days after the first administration, and wherein the immune response against toxin A and/or toxin B is sustained.

Immunogenic Compositions For Use In Pneumococcal Vaccines

US Patent:
2020023, Jul 30, 2020
Filed:
Apr 9, 2020
Appl. No.:
16/844060
Inventors:
- New York NY, US
Kathrin Ute Jansen - New York NY, US
Michael William Pride - Staten Island NY, US
International Classification:
A61K 39/09
A61K 39/385
Abstract:
An object of the present invention is to provide immunogenic compositions for protection against , in particular against serogroup 9, while limiting the number of conjugates. The present invention therefore relates to new immunogenic compositions for use in pneumococcal vaccines and to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said immunogenic compositions.

Immunogenic Compositions For Use In Pneumococcal Vaccines

US Patent:
2019034, Nov 14, 2019
Filed:
Jan 5, 2018
Appl. No.:
16/478265
Inventors:
- New York NY, US
Kathrin Ute Jansen - New York NY, US
Michael William Pride - Staten Island NY, US
International Classification:
A61K 39/09
A61K 39/39
Abstract:
An object of the present invention is to provide immunogenic compositions for protection against , in particular against serogroup 18, while limiting the number of conjugates. The present invention therefore relates to new immunogenic compositions for use in pneumococcal vaccines and to vaccination of human subjects, in particular infants and elderly, against pneumoccocal infections using said immunogenic compositions.

Immunogenic Compositions For Use In Pneumococcal Vaccines

US Patent:
2018000, Jan 4, 2018
Filed:
Jan 5, 2016
Appl. No.:
15/542802
Inventors:
- New york NY, US
Kathrin Ute Jansen - New York NY, US
Michael William Pride - Staten Island NY, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 39/09
A61K 39/385
A61K 39/00
Abstract:
An object of the present invention is to provide immunogenic compositions for protection against , in particular against serogroup 9, while limiting the number of conjugates. The present invention thereforerelates to new immunogenic compositions for use in pneumococcal vaccines and to vaccination of human subjects, in particular infants and elderly, against pneumoccocal infections using said immunogenic compositions.

Possible Relatives

Debra J Pride  Daniel E Pride  Denise Pride  Danny D Pride  Daphene D Pride  Derick L Pride  Darryl E Pride  Michael C Last  Michael C Johnson  Michael F Stamps 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.